Skip to main content

Table 1 Clinical and pathological characteristics of patient populations

From: Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer

  NPT BPH HGPIN PCa
Number of patients 10 26 37 121
Age, median (range) 60 (50–80) 68 (54–79) 65 (40–74) 64 (40–74)
PSA, ng/mL, median (range) n.av. 5.8 (0.8-32.5) 8.03 (3.35-16.9) 9.3 (3.1-48.3)
Gleason score, median (range) n.a. n.a. n.a. 7 (4–9)
Pathological stage (%)     
pT2 n.a. n.a. n.a. 63 (52.1%)
pT3 n.a. n.a. n.a. 58 (47.9%)
  1. NPT - morphologically normal prostate tissue, BPH - benign prostatic hyperplasia, HGPIN - high grade prostatic intraepithelial neoplasia, PCa - prostate carcinoma, n.av. not available and n.a. - not applicable.
\